As of November 6, 2026, Krystal Biotech Inc is a publicly traded company (Nasdaq: KRYS); its largest reported holder is BlackRock, with 11.6% on Schedule 13G/A of October 27, 2026, then Krish S. Krishnan (11.5%). No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G/A, October 27, 2026).
Is this your company?
About to sign with, pay or invest in Krystal Biotech Inc? See the free Snapshot first.
Free to see. No signup.
Is Krystal Biotech Inc a real, registered company?
- Krystal Biotech Inc files with the SEC under CIK 1711279 (its SEC filings).
- Its shares are listed under the ticker KRYS on Nasdaq (SEC company record).
- business address in Pittsburgh, Pennsylvania, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Krystal Biotech Inc in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2026-10-27).
Who are Krystal Biotech Inc's owners and officers?
Krystal Biotech Inc: business address in Pittsburgh, Pennsylvania; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-10-30).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-30 | Vanguard Portfolio Management | 4.43% |
| Schedule 13G/A, 2026-10-27 | Blackrock, Inc. | 11.6% |
| Schedule 13G/A, 2026-05-04 | Krish S. Krishnan | 11.5% |
| Schedule 13G, 2026-04-29 | Vanguard Portfolio Management | 5.05% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
Questions about who owns Krystal Biotech Inc
Who owns Krystal Biotech Inc?
On this page, 2 holders' latest ownership filings report 5% or more of Krystal Biotech Inc: Blackrock, Inc. (11.6%, Schedule 13G/A, filed 2026-10-27) and Krish S. Krishnan (11.5%, Schedule 13G/A, filed 2026-05-04).
Who are the largest shareholders of Krystal Biotech Inc?
By the share each holder's latest filing reports, the largest holders of Krystal Biotech Inc on this page are Blackrock, Inc. (11.6%) and Krish S. Krishnan (11.5%).
When did Blackrock, Inc. buy into Krystal Biotech Inc?
The filings give report dates, not purchase dates. The earliest filing from Blackrock, Inc. on this page is the Schedule 13G/A, filed 2026-10-27, reporting 11.6%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Krystal Biotech Inc?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Krystal Biotech Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Krystal Biotech Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
How much has Krystal Biotech Inc raised?
No fundraising or offering filing from Krystal Biotech Inc is on file with us.
Keep reading
More on Krystal Biotech Inc and the records around it.
Companies that share a holder
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/krystal-biotech